Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects
Clinical trial NCT04865536 · COMPLETED
Trial details
- NCT number
- NCT04865536
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2021-05-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.